225 related articles for article (PubMed ID: 25180131)
1. Treatment of asymptomatic hyperuricemia for the prevention of gouty arthritis, renal disease, and cardiovascular events: a systematic literature review.
Vinik O; Wechalekar MD; Falzon L; Buchbinder R; van der Heijde DM; Bombardier C
J Rheumatol Suppl; 2014 Sep; 92():70-4. PubMed ID: 25180131
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic gouty arthritis: it is not just about urate-lowering therapy.
Schlesinger N
Semin Arthritis Rheum; 2012 Oct; 42(2):155-65. PubMed ID: 22542277
[TBL] [Abstract][Full Text] [Related]
3. Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis.
Kanji T; Gandhi M; Clase CM; Yang R
BMC Nephrol; 2015 Apr; 16():58. PubMed ID: 25928556
[TBL] [Abstract][Full Text] [Related]
4. [Gout and hyperuricaemia--should both be treated?].
Uhlig T
Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2878-80. PubMed ID: 14600714
[TBL] [Abstract][Full Text] [Related]
5. Challenges associated with the management of gouty arthritis in patients with chronic kidney disease: a systematic review.
Curiel RV; Guzman NJ
Semin Arthritis Rheum; 2012 Oct; 42(2):166-78. PubMed ID: 22560299
[TBL] [Abstract][Full Text] [Related]
6. Caffeoylquinic acid derivatives rich extract from Gnaphalium pensylvanicum willd. Ameliorates hyperuricemia and acute gouty arthritis in animal model.
Jiang Y; Lin Y; Hu YJ; Song XJ; Pan HH; Zhang HJ
BMC Complement Altern Med; 2017 Jun; 17(1):320. PubMed ID: 28623927
[TBL] [Abstract][Full Text] [Related]
7. Effect of Urate Lowering Therapy on Renal Disease Progression in Hyperuricemic Patients with Chronic Kidney Disease.
Kim Y; Shin S; Kim K; Choi S; Lee K
J Rheumatol; 2015 Nov; 42(11):2143-8. PubMed ID: 26428209
[TBL] [Abstract][Full Text] [Related]
8. A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arthritis in the province of Ontario.
Bellamy N; Gilbert JR; Brooks PM; Emmerson BT; Campbell J
J Rheumatol; 1988 Dec; 15(12):1841-7. PubMed ID: 3265960
[TBL] [Abstract][Full Text] [Related]
9. Gouty Arthritis: A Review of Acute Management and Prevention.
Wilson L; Saseen JJ
Pharmacotherapy; 2016 Aug; 36(8):906-22. PubMed ID: 27318031
[TBL] [Abstract][Full Text] [Related]
10. [How to select and use urate lowering agents for hyperuricemia].
Yamanaka H
Nihon Rinsho; 1996 Dec; 54(12):3261-5. PubMed ID: 8976102
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy.
Shoji A; Yamanaka H; Kamatani N
Arthritis Rheum; 2004 Jun; 51(3):321-5. PubMed ID: 15188314
[TBL] [Abstract][Full Text] [Related]
12. Difficult-to-treat gouty arthritis: a disease warranting better management.
Schlesinger N
Drugs; 2011 Jul; 71(11):1413-39. PubMed ID: 21812506
[TBL] [Abstract][Full Text] [Related]
13. Management of acute and chronic gouty arthritis: present state-of-the-art.
Schlesinger N
Drugs; 2004; 64(21):2399-416. PubMed ID: 15481999
[TBL] [Abstract][Full Text] [Related]
14. Luteolin-4'-O-glucoside and its aglycone, two major flavones of Gnaphalium affine D. Don, resist hyperuricemia and acute gouty arthritis activity in animal models.
Lin Y; Liu PG; Liang WQ; Hu YJ; Xu P; Zhou J; Pu JB; Zhang HJ
Phytomedicine; 2018 Mar; 41():54-61. PubMed ID: 29519319
[TBL] [Abstract][Full Text] [Related]
15. Uricosuric medications for chronic gout.
Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
[TBL] [Abstract][Full Text] [Related]
16. Effects of Gnaphalium affine D. Don on hyperuricemia and acute gouty arthritis.
Zhang HJ; Li LN; Zhou J; Yang QQ; Liu PG; Xu P; Liang WQ; Cheng L; Zhang YQ; Pu JB; Hu YJ
J Ethnopharmacol; 2017 May; 203():304-311. PubMed ID: 28390941
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for hyperuricemia in hypertensive patients.
Gois PH; Souza ER
Cochrane Database Syst Rev; 2013 Jan; (1):CD008652. PubMed ID: 23440832
[TBL] [Abstract][Full Text] [Related]
18. [Gout].
Gröbner W; Zöllner N
Z Rheumatol; 2004 Feb; 63(1):2-9. PubMed ID: 14991273
[TBL] [Abstract][Full Text] [Related]
19. Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia.
Levy GD; Rashid N; Niu F; Cheetham TC
J Rheumatol; 2014 May; 41(5):955-62. PubMed ID: 24692523
[TBL] [Abstract][Full Text] [Related]
20. Anti-hyperuricemic and anti-gouty arthritis activities of polysaccharide purified from Lonicera japonica in model rats.
Yang Q; Wang Q; Deng W; Sun C; Wei Q; Adu-Frimpong M; Shi J; Yu J; Xu X
Int J Biol Macromol; 2019 Feb; 123():801-809. PubMed ID: 30445085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
